Benjamin Comer bio
Ben Comer is senior editor at Pharmaceutical Executive. Prior to joining PE, he worked as a reporter for several years at Haymarket Media's Medical Marketing & Media magazine, covering professional and consumer pharmaceutical marketing strategy and tactics, traditional and digital media, and U.S. regulatory policy. Ben is a licensed but no-longer-practicing pharmaceutical technician, and a voracious reader. In 2005, he received an undergraduate degree in journalism and media studies from the College of Charleston, South Carolina, and taught an English language class in Zhuji, China, in 2004, though he unfortunately speaks very little Mandarin. Ben’s reportage at Medical Marketing & Media (MM&M) has been published variously in aggregate online, and his work has also appeared in PR Week and Direct Marketing News, sister titles to MM&M, and most recently the Green Hills News, a local newspaper in Nashville, Tennessee. Aside from journalistic endeavors, Ben has worked as a boom operator on independent films in the New York City area, a bike courier (very briefly), a screenwriter (unpaid), and an unpublished fiction writer.
Planning for Unique Challenges Faced by Cell & Gene Therapy Developers
May 8th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Lattanzi, VP, Emerging Therapies, Cencora, discusses the unique challenges that developers of cell and gene therapies need to plan for when building their channel strategy.
The State of Mining Data Insights in the Life Sciences Industry – 2024
April 30th 2024A Frost & Sullivan industry-wide survey reveals which insights most pharmaceutical companies have mastered and which are still painful or impossible to extract and details the complexity of the process, the confidence companies have in their findings, and more. Hear Web Sun, President and Co-founder of Komodo Health, share what's driving these challenges and how you can overcome them.